Page last updated: 2024-09-02

s 9788 and Colorectal Neoplasms

s 9788 has been researched along with Colorectal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Backx, A; Bleiberg, H; De Mulder, PH; Gerard, B; Hecquet, B; Lucas, C; Punt, CJ; Tueni, E; Van Oosterom, AT; Voest, EE	1

Trials

1 trial(s) available for s 9788 and Colorectal Neoplasms

Article	Year
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer. British journal of cancer, 1997, Volume: 76, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Multiple; Electrocardiography; Heart; Humans; Kidney Neoplasms; Middle Aged; Piperidines; Triazines	1997

Article

Year

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.

British journal of cancer, 1997, Volume: 76, Issue:10

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Multiple; Electrocardiography; Heart; Humans; Kidney Neoplasms; Middle Aged; Piperidines; Triazines

1997